ProSolus expands manufacturing capacity with second transdermal production line in Boerne

ProSolus, a subsidiary of Mission Pharmacal, installed a second transdermal production facility at Mission's Boerne, Texas location, more than doubling total transdermal product output to over 100 million patches annually.

“ProSolus recently expanded its state-of-the-art commercial manufacturing capabilities by installing a second transdermal production facility as part of Mission's Boerne, Texas, manufacturing location.”prosoluspharma.com

• 1 source
• prosoluspharma.comProSolus Seeks Higher Utilization of Transdermal Drug Delivery Technology - ProSolus, Inc.ProSolus PharmaApr 27, 2017

Summarized from public sources; check the original articles before acting on it.